Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Fuji
Citi
Queensland Health
Moodys
UBS
Colorcon
Chinese Patent Office
Julphar
Covington

Generated: January 21, 2018

DrugPatentWatch Database Preview

ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for atropine sulfate; diphenoxylate hydrochloride and what is the scope of atropine sulfate; diphenoxylate hydrochloride freedom to operate?

Atropine sulfate; diphenoxylate hydrochloride
is the generic ingredient in ten branded drugs marketed by Scherer Rp, Medpointe Pharm Hlc, West-ward Pharms Int, Alpharma Us Pharms, Gd Searle Llc, Md Pharm, Able, Ani Pharms Inc, Ascot, Heather, Hikma Pharms, Inwood Labs, Kv Pharm, Lannett, Lederle, Mylan, Par Pharm, Parke Davis, Pvt Form, R And S Pharma, Roxane, Sandoz, Sun Pharm Industries, Usl Pharma, Valeant Pharm Intl, Watson Labs, Vangard, Superpharm, and Halsey, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for atropine sulfate; diphenoxylate hydrochloride. Thirty-two suppliers are listed for this compound.
Summary for ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
Pharmacology for ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE

US Patents and Regulatory Information for ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 087131-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vangard LO-TROL atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 088009-001 Mar 25, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hikma Pharms DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 087765-001 Mar 15, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roxane DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 086057-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 086727-001 Approved Prior to Jan 1, 1982 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Superpharm LOGEN atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 088962-001 May 10, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Scherer Rp DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride CAPSULE;ORAL 086440-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 085762-001 Approved Prior to Jan 1, 1982 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kv Pharm DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 085659-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pvt Form DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 085766-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Deloitte
Dow
Cerilliant
Julphar
Merck
Moodys
Express Scripts
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot